|
RTN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.923000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.880700E-03 |
| Normal-vs-Stage2 |
6.936100E-03 |
| Normal-vs-Stage3 |
2.107000E-01 |
| Normal-vs-Stage4 |
7.959800E-01 |
| Stage1-vs-Stage2 |
9.423600E-01 |
| Stage1-vs-Stage3 |
1.879390E-01 |
| Stage1-vs-Stage4 |
2.234600E-01 |
| Stage2-vs-Stage3 |
2.254600E-01 |
| Stage2-vs-Stage4 |
2.259000E-01 |
| Stage3-vs-Stage4 |
5.522200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.159000E-03 |
| Normal-vs-AfricanAmerican |
6.096100E-02 |
| Normal-vs-Asian |
3.708400E-01 |
| Caucasian-vs-AfricanAmerican |
4.277900E-02 |
| Caucasian-vs-Asian |
7.836800E-01 |
| AfricanAmerican-vs-Asian |
8.525800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.603640E-03 |
| Normal-vs-Female |
3.144000E-01 |
| Male-vs-Female |
4.579200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.815700E-02 |
| Normal-vs-Extreme_Weight |
6.778100E-04 |
| Normal-vs-Obese |
2.924500E-02 |
| Normal-vs-Extreme_Obese |
3.242100E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.172100E-02 |
| Normal_Weight-vs-Obese |
9.521600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.603600E-01 |
| Extreme_Weight-vs-Obese |
3.036500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.069000E-01 |
| Obese-vs-Extreme_Obese |
2.974000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.420200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.875300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.298300E-03 |
| Normal-vs-Age(81-100Yrs) |
4.426400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.747000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.115800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.056000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.244160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.343800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.879200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.077000E-03 |
| Normal-VS-Type2 PRCC |
4.561300E-04 |
| Normal-VS-KIRP CIMP |
2.636600E-03 |
| Normal-VS-Unclassified PRCC |
1.031360E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.628800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.355100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.826000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.19569998346947E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
4.751900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.72799999987161E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.375600E-04 |
| Normal-vs-N1 |
8.893200E-01 |
| Normal-vs-N2 |
6.014400E-01 |
| N0-vs-N1 |
2.864000E-03 |
| N0-vs-N2 |
6.112400E-01 |
| N1-vs-N2 |
5.796000E-01 |
|
|
